交易 Lantern Pharma Inc. - LTRN CFD
新增到我的最愛- 概括
- 曆史數據
- 活動
- 收入報表
- 資産負債表
- 現金流
- 所有權
交易條件
價差 | 0.15 | ||||||||
多頭倉位隔夜費用
多頭倉位隔夜費用
前往平台 | -0.026151% | ||||||||
空頭倉位隔夜費用
空頭倉位隔夜費用
前往平台 | 0.003929% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 5% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 關閉 | 更改 | 變化 (%) | 打開 | 高 | 低 |
---|---|---|---|---|---|---|
Sep 29, 2023 | 3.39 | 0.00 | 0.00% | 3.39 | 3.50 | 3.38 |
Sep 28, 2023 | 3.43 | -0.21 | -5.77% | 3.64 | 3.65 | 3.38 |
Sep 27, 2023 | 3.73 | 0.01 | 0.27% | 3.72 | 3.81 | 3.67 |
Sep 26, 2023 | 3.47 | -0.08 | -2.25% | 3.55 | 3.65 | 3.32 |
Sep 25, 2023 | 3.48 | -0.31 | -8.18% | 3.79 | 3.79 | 3.32 |
Sep 22, 2023 | 3.63 | -0.05 | -1.36% | 3.68 | 3.73 | 3.63 |
Sep 21, 2023 | 3.68 | -0.06 | -1.60% | 3.74 | 3.85 | 3.68 |
Sep 20, 2023 | 3.81 | -0.02 | -0.52% | 3.83 | 3.87 | 3.73 |
Sep 19, 2023 | 3.88 | 0.05 | 1.31% | 3.83 | 3.91 | 3.83 |
Sep 18, 2023 | 3.84 | -0.12 | -3.03% | 3.96 | 3.98 | 3.83 |
Sep 15, 2023 | 3.99 | -0.13 | -3.16% | 4.12 | 4.14 | 3.93 |
Sep 14, 2023 | 4.13 | -0.09 | -2.13% | 4.22 | 4.23 | 4.08 |
Sep 13, 2023 | 4.24 | 0.04 | 0.95% | 4.20 | 4.35 | 4.19 |
Sep 12, 2023 | 4.22 | -0.16 | -3.65% | 4.38 | 4.38 | 4.19 |
Sep 11, 2023 | 4.31 | -0.09 | -2.05% | 4.40 | 4.40 | 4.31 |
Sep 8, 2023 | 4.40 | 0.01 | 0.23% | 4.39 | 4.48 | 4.39 |
Sep 7, 2023 | 4.32 | 0.04 | 0.93% | 4.28 | 4.32 | 4.28 |
Sep 6, 2023 | 4.30 | -0.09 | -2.05% | 4.39 | 4.39 | 4.23 |
Sep 5, 2023 | 4.44 | -0.15 | -3.27% | 4.59 | 4.60 | 4.38 |
Sep 1, 2023 | 4.54 | 0.09 | 2.02% | 4.45 | 4.64 | 4.38 |
Lantern Pharma Inc. Events
时间(协调世界时) (UTC) | 國家 | 事件 |
---|---|---|
Monday, November 6, 2023 | ||
时间(协调世界时) (UTC) 10:59 | 國家 US
| 事件 Q3 2023 Lantern Pharma Inc. Earnings Release Q3 2023 Lantern Pharma Inc. Earnings ReleaseForecast(預報) -上一頁 - |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 0 | 0 |
總營業費用 | 14.4327 | 12.4825 | 5.90819 | 2.42819 | 1.72642 |
銷售/一般/行政費用,總計 | 5.8298 | 5.02093 | 3.66497 | 1.475 | 1.15432 |
研究與開發 | 8.60295 | 7.57058 | 2.24323 | 0.95319 | 0.5721 |
營業收入 | -14.4327 | -12.4825 | -5.90819 | -2.42819 | -1.72642 |
稅前淨收入 | -14.2599 | -12.363 | -5.90819 | -2.42819 | -1.72642 |
稅後淨收入 | -14.2599 | -12.363 | -5.90819 | -2.42819 | -1.72642 |
未計算非常項目前的淨收益 | -14.2599 | -12.363 | -5.90819 | -2.42819 | -1.72642 |
淨收入 | -14.2599 | -12.363 | -5.90819 | -2.42819 | -1.72642 |
普通股股東可獲收益 (不含非經常性項目) | -14.2599 | -12.363 | -5.90819 | -2.42819 | -1.72642 |
普通股股東可獲收益 (含非經常性項目) | -14.2599 | -12.363 | -5.90819 | -2.42819 | -1.72642 |
攤薄淨收入 | -14.2599 | -12.363 | -5.90819 | -2.42819 | -1.72642 |
攤薄後加權平均股 | 10.8506 | 10.9049 | 6.22093 | 6.03059 | 6.03059 |
扣除特別項目的每股攤薄盈利 | -1.31421 | -1.13371 | -0.94973 | -0.40264 | -0.28628 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | |||
每股正常攤薄盈利 | -1.31421 | -1.14371 | -0.94973 | -0.40264 | -0.28628 |
異常費用(收入) | -0.109 | ||||
利息收入(費用),非經營淨值 | 0.20436 | 0.11948 | |||
其他,淨值 | -0.03155 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 0 | 0 |
總營業費用 | 4.28627 | 3.82628 | 2.14526 | 4.39482 | 4.0664 |
銷售/一般/行政費用,總計 | 1.73332 | 1.57468 | 1.44296 | 1.406 | 1.40616 |
研究與開發 | 2.55295 | 2.2516 | 0.7023 | 2.98882 | 2.66024 |
營業收入 | -4.28627 | -3.82628 | -2.14526 | -4.39482 | -4.0664 |
稅前淨收入 | -3.86777 | -3.38111 | -2.26468 | -4.49239 | -4.12177 |
稅後淨收入 | -3.86777 | -3.38111 | -2.26468 | -4.49239 | -4.12177 |
未計算非常項目前的淨收益 | -3.86777 | -3.38111 | -2.26468 | -4.49239 | -4.12177 |
淨收入 | -3.86777 | -3.38111 | -2.26468 | -4.49239 | -4.12177 |
普通股股東可獲收益 (不含非經常性項目) | -3.86777 | -3.38111 | -2.26468 | -4.49239 | -4.12177 |
普通股股東可獲收益 (含非經常性項目) | -3.86777 | -3.38111 | -2.26468 | -4.49239 | -4.12177 |
攤薄淨收入 | -3.86777 | -3.38111 | -2.26468 | -4.49239 | -4.12177 |
攤薄後加權平均股 | 10.857 | 10.8571 | 10.8389 | 10.8309 | 10.8758 |
扣除特別項目的每股攤薄盈利 | -0.35624 | -0.31142 | -0.20894 | -0.41477 | -0.37899 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -0.35624 | -0.31142 | -0.20894 | -0.41477 | -0.37899 |
異常費用(收入) | |||||
利息收入(費用),非經營淨值 | 0.13378 | 0.07468 | 0.05222 | 0.05503 | 0.02242 |
其他,淨值 | 0.28472 | 0.37049 | -0.17165 | -0.15259 | -0.0778 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 58.7227 | 72.7164 | 20.2369 | 1.23282 | 0.44516 |
現金和短期投資 | 55.1961 | 70.7254 | 19.2292 | 1.23203 | 0.44516 |
現金 | 37.2018 | 51.5243 | 19.2292 | 1.23203 | 0.44516 |
總資産 | 58.8363 | 73.9505 | 20.3596 | 1.43258 | 0.44983 |
物業/廠房/設備,總計 - 淨額 | 0.0957 | 0.21619 | 0.02151 | 0.00876 | 0.00467 |
其他長期資産,總計 | 0.01789 | 1.01789 | 0.10121 | 0.191 | 0 |
流動負債總額 | 2.7983 | 2.32617 | 0.55234 | 0.48929 | 0.65163 |
Payable/Accrued | 2.74541 | 2.17411 | 0.55234 | 0.48929 | 0.11663 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 0.535 | ||||
負債總額 | 2.7983 | 2.37906 | 0.66084 | 0.48929 | 0.65163 |
長期債務總額 | 0 | 0 | 0.1085 | 0 | 0 |
總權益 | 56.038 | 71.5714 | 19.6988 | 0.94328 | -0.2018 |
Redeemable Preferred Stock | 0.01402 | 0.00743 | |||
普通股 | 0.00109 | 0.00111 | 0.00062 | 0.01137 | 0.01137 |
額外實收資本 | 95.6912 | 96.6859 | 32.3581 | 7.6696 | 4.10292 |
留存收益(累計赤字) | -39.2829 | -25.0229 | -12.6599 | -6.75171 | -4.32352 |
總負債和股東權益 | 58.8363 | 73.9505 | 20.3596 | 1.43258 | 0.44983 |
已發行普通股總數 | 10.857 | 11.0888 | 6.22093 | 6.03059 | 6.03059 |
預付的費用 | 2.98547 | 1.99095 | 1.00769 | 0.00079 | |
長期債務 | 0 | 0.1085 | |||
短期投資 | 17.9943 | 19.2012 | |||
預提費用 | 0.05289 | 0.15206 | |||
其他負債,總計 | 0 | 0.05289 | |||
其他權益,總計 | -0.37139 | -0.09269 | |||
其他流動資産,總計 | 0.54118 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
流動資産總額 | 55.1676 | 58.7227 | 62.0198 | 65.663 | 67.6632 |
現金和短期投資 | 51.5401 | 55.1961 | 57.8266 | 62.1495 | 65.2165 |
現金 | 32.4788 | 37.2018 | 39.2579 | 43.3629 | 46.6517 |
預付的費用 | 3.08633 | 2.98547 | 3.65197 | 3.51349 | 2.44668 |
總資産 | 55.5093 | 58.8363 | 62.1644 | 66.3798 | 68.4025 |
物業/廠房/設備,總計 - 淨額 | 0.30879 | 0.0957 | 0.12673 | 0.15775 | 0.18029 |
其他長期資産,總計 | 0.03297 | 0.01789 | 0.01789 | 0.55907 | 0.55907 |
流動負債總額 | 2.79319 | 2.7983 | 3.139 | 5.30429 | 3.07385 |
Payable/Accrued | 2.6736 | 2.74541 | 3.04697 | 5.17359 | 2.91865 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
負債總額 | 2.93382 | 2.7983 | 3.139 | 5.30429 | 3.08715 |
長期債務總額 | 0 | 0 | 0 | 0 | 0 |
長期債務 | |||||
總權益 | 52.5755 | 56.038 | 59.0254 | 61.0755 | 65.3154 |
普通股 | 0.00109 | 0.00109 | 0.00109 | 0.00108 | 0.00108 |
額外實收資本 | 96.0247 | 95.6912 | 95.3611 | 95.06 | 94.7705 |
留存收益(累計赤字) | -43.1506 | -39.2829 | -35.9018 | -33.6371 | -29.1447 |
總負債和股東權益 | 55.5093 | 58.8363 | 62.1644 | 66.3798 | 68.4025 |
已發行普通股總數 | 10.857 | 10.857 | 10.857 | 10.8309 | 10.8309 |
短期投資 | 19.0613 | 17.9943 | 18.5687 | 18.7866 | 18.5648 |
預提費用 | 0.11958 | 0.05289 | 0.09202 | 0.13071 | 0.15519 |
其他流動負債,總計 | |||||
其他負債,總計 | 0.14063 | 0 | 0 | 0 | 0.0133 |
其他權益,總計 | -0.29968 | -0.37139 | -0.43504 | -0.34848 | -0.31147 |
其他流動資産,總計 | 0.54118 | 0.54118 | 0.54118 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
淨收入/起跑線 | -14.2599 | -12.363 | -5.90819 | -2.42819 | -1.72642 |
經營活動産生的現金 | -12.7675 | -10.5915 | -5.65162 | -2.12792 | -1.27152 |
非現金物品 | 2.09424 | 1.16477 | 1.19224 | 0.11776 | 0.18306 |
營運資金的變化 | -0.61186 | 0.59996 | -0.93906 | 0.18088 | 0.27184 |
投資活動産生的現金 | 0.17927 | -19.5306 | -0.01614 | -0.00572 | 0.00534 |
其他投資現金流量項目,總計 | 0.20711 | -19.5151 | 0.00534 | ||
融資活動産生的現金 | -2.1825 | 63.4161 | 23.665 | 2.92051 | 0.535 |
融資現金流項目 | 0 | -4.78382 | -2.74554 | 0 | 0.535 |
股票的發行(報廢),淨額 | -2.1825 | 68.1999 | 26.302 | 2.92051 | 0 |
現金淨變化 | -14.7813 | 33.2951 | 17.9972 | 0.78687 | -0.73118 |
經營活動産生的現金 | 0.01008 | 0.00676 | 0.00339 | 0.00163 | |
資本支出 | -0.02784 | -0.0155 | -0.01614 | -0.00572 | |
債務的發行(退還),淨額 | 0 | 0.1085 | |||
外彙效應 | -0.01061 | 0.00107 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -3.86777 | -14.2599 | -10.8788 | -8.61416 | -4.12177 |
Cash From Operating Activities | -3.75716 | -12.7675 | -10.0986 | -6.06036 | -3.32773 |
Cash From Operating Activities | 0.00342 | 0.01008 | 0.00732 | 0.00437 | 0.00199 |
Non-Cash Items | 0.34754 | 2.09424 | 1.76509 | 1.16612 | 0.5284 |
Changes in Working Capital | -0.24035 | -0.61186 | -0.9922 | 1.3833 | 0.26366 |
Cash From Financing Activities | 0 | -2.1825 | -2.1825 | -2.1825 | -2.1825 |
Financing Cash Flow Items | 0 | 0 | 0 | 0 | |
Issuance (Retirement) of Stock, Net | 0 | -2.1825 | -2.1825 | -2.1825 | -2.1825 |
Issuance (Retirement) of Debt, Net | |||||
Net Change in Cash | -4.72302 | -14.7813 | -12.7252 | -8.62025 | -5.33143 |
Cash From Investing Activities | -0.96088 | 0.17927 | -0.42359 | -0.34923 | 0.17652 |
Capital Expenditures | -0.00888 | -0.02784 | -0.02089 | -0.01418 | |
Other Investing Cash Flow Items, Total | -0.952 | 0.20711 | -0.4027 | -0.33505 | 0.17652 |
Foreign Exchange Effects | -0.00498 | -0.01061 | -0.02051 | -0.02816 | 0.00228 |
投資者名稱 | 投資者類型 | 流通股百分比 | 持有股份 | 股份變動 | 持有日期 | 換手率 |
---|---|---|---|---|---|---|
Bios Equity Partners, LP. | Venture Capital | 14.1044 | 1533018 | -323907 | 2023-04-15 | LOW |
Biological Mimetics, Inc | Corporation | 8.6894 | 944458 | -13807 | 2023-04-15 | LOW |
Prophase Labs Inc | Corporation | 8.3724 | 910000 | 0 | 2023-04-15 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 3.3807 | 367454 | 0 | 2023-06-30 | LOW |
GWM Advisors LLC | Investment Advisor | 1.5776 | 171465 | -650 | 2023-06-30 | LOW |
Carlson Capital, L.P. | Hedge Fund | 0.874 | 95000 | -29900 | 2023-06-30 | HIGH |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.8283 | 90026 | 32252 | 2023-06-30 | LOW |
CM Management, LLC | Investment Advisor | 0.69 | 75000 | 15000 | 2023-06-30 | LOW |
Redmond Asset Management, LLC | Investment Advisor | 0.4288 | 46604 | -2585 | 2023-06-30 | LOW |
Renaissance Technologies LLC | Hedge Fund | 0.4131 | 44900 | 20300 | 2023-06-30 | HIGH |
Keyser (Donald Jeffrey PH.D) | Individual Investor | 0.3857 | 41927 | 0 | 2023-04-15 | LOW |
Horizon Kinetics LLC | Investment Advisor/Hedge Fund | 0.276 | 30000 | 0 | 2023-06-30 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.2553 | 27752 | 0 | 2023-06-30 | LOW |
UBS Financial Services, Inc. | Investment Advisor | 0.2484 | 27000 | 0 | 2023-06-30 | LOW |
Newton Investment Management North America, LLC | Investment Advisor | 0.2436 | 26480 | 0 | 2023-06-30 | MED |
WWM Financial | Investment Advisor | 0.2313 | 25145 | -1333 | 2023-06-30 | LOW |
Citadel Advisors LLC | Hedge Fund | 0.2276 | 24737 | 13761 | 2023-06-30 | LOW |
Incrementum AG | Investment Advisor | 0.1738 | 18888 | 0 | 2023-06-30 | MED |
Sigma Planning Corporation | Investment Advisor | 0.1668 | 18125 | 850 | 2023-06-30 | LOW |
Commonwealth Financial Network | Investment Advisor | 0.1547 | 16813 | -3373 | 2023-06-30 | LOW |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
投資
交易規模(槓桿 x 投資):
打開
關閉
做空 做多
Industry: | Biotechnology & Medical Research (NEC) |
1920 Mckinney Avenue
7th Floor
DALLAS
TEXAS 75201
US
收入報表
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 555.000 多名交易者,選擇與 Capital.com 交易